Antimaláricos en el tratamiento del lupus eritematoso / Antimalarials in the treatment of lupus erythematosus
VozAndes
;
27(1): 6-6, 2016.
Article
in Spanish
| LILACS
| ID: biblio-999418
RESUMEN
De la evidencia disponible, la hidroxicloroquina puede ser preferible por tener un menor riesgo de toxicidad ocular y de efectos gastrointestinales [2] y una efcacia algo mayor que la cloroquina [7]. Considerando que el uso de estos antimaláricos en pacientes con lupus eritematoso (y otros cuadros autoinmunes) será cada vez mayor, los distintos profesionales médicos deben recordar que su empleo está contraindicado en sujetos con retinopatías preexistentes, trastornos sanguíneos y miastenia gravis, al tiempo de estar atentos al aparecimiento de efectos adversos serios como una cardiotoxicidad y neuromiotoxicidad (AU)
ABSTRACT
From the available evidence, hydroxychloroquine can be preferable for having a lower risk of ocular toxicity and effects Gastrointestinal [2] and an efcacia somewhat larger than chloroquine [7]. Whereas the use of these antimalarials in patients with lupus erythematosus (and other pictures autoimmune) will be increasing, the different medical professionals they must remember that their employment is contraindicated in subjects with pre-existing retinopathies, blood disorders and myasthenia gravis, while being attentive to the occurrence of adverse effects serious as a cardiotoxicity and neuromyotoxicity.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Therapeutics
/
Lupus Erythematosus, Cutaneous
/
Antimalarials
Limits:
Humans
Language:
Spanish
Journal:
VozAndes
Journal subject:
Medicine
Year:
2016
Type:
Article
Affiliation country:
Ecuador
Institution/Affiliation country:
Universidad Central del Ecuador/EC
Similar
MEDLINE
...
LILACS
LIS